Welcome to our dedicated page for Sonendo news (Ticker: SONX), a resource for investors and traders seeking the latest updates and insights on Sonendo stock.
Sonendo Inc (SONX) is a leader in dental technology innovation, specializing in advanced endodontic solutions through its multisonic ultracleaning systems. This page aggregates all verified corporate announcements, financial disclosures, and clinical developments related to SONX.
Key updates include quarterly earnings reports, regulatory filings, product launch details, and partnership announcements. Investors gain insights into business performance while dental professionals track technological advancements in minimally invasive root canal therapy.
Regular updates cover clinical study results, intellectual property milestones, and operational expansions. All content is sourced from official releases to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to SONX's evolving position in dental technology. Check back frequently to stay informed about developments impacting both clinical practice and investment considerations.
Sonendo (NYSE: SONX) is participating in the American Association of Endodontists’ Annual Meeting from April 27-30, 2022, in Phoenix, AZ. The event marks the first in-person meeting since 2019, expecting over 3,000 industry professionals. Sonendo will showcase its new CleanFlow procedure instrument designed for a less invasive root canal experience. Attendees can engage in hands-on demonstrations of the GentleWave System and attend lectures from key opinion leaders. Sonendo aims to enhance adoption of its technology and network with peers.
Sonendo, Inc. (NYSE: SONX) has launched the CleanFlow™ procedure instrument for its GentleWave® System, aimed at enhancing root canal therapy. This new technology simplifies workflow, minimizes steps for practitioners, and significantly improves patient experience, with 99.5% of patients reporting no pain during the procedure. With over 800,000 GentleWave procedures completed, Sonendo demonstrates strong market adoption and commitment to innovation in dental technology.
Sonendo, Inc. (NYSE: SONX) will announce its financial results for Q1 2022 on May 10, 2022, after market close. A conference call will follow at 1:30 PM PT. Interested investors can listen via phone or through a live webcast on the company’s website. Sonendo is recognized for its GentleWave® System, aimed at treating tooth decay more efficiently while preserving tooth structure. The company will also participate in the Bank of America Healthcare Conference on May 11, 2022, featuring a fireside chat at 10:40 AM PT.
Sonendo, Inc. (NYSE: SONX) has launched the GentleWave Community app, aimed at enhancing endodontic practices. This industry-first application enables GentleWave providers to exchange clinical insights and treatment tips in a private forum. The app is accessible on both iOS and Android platforms, offering features like push notifications and real-time engagement. This initiative is part of Sonendo's commitment to support the specialty of endodontics and improve doctor and patient experiences. It complements existing digital tools such as TDO, Sonendo's practice management software.
Sonendo, a dental technology company traded as NYSE:SONX, is set to present at the Piper Sandler Dental Day on March 29 at 12:00 p.m. ET. CEO Bjarne Bergheim and CFO Michael Watts will discuss the GentleWave® System, which treats tooth decay with minimal invasiveness. This innovative system improves clinical outcomes significantly compared to traditional methods, leading to rapid healing and reduced post-operative pain. Additionally, Sonendo owns TDO® Software, enhancing dental practice management.
Sonendo, a leading dental technology company, reported its financial results for Q4 and the full year 2021. Total revenue for Q4 reached $9.9 million, a 14% increase year-over-year, and $33.2 million for the entire year, marking a 42% growth from 2020. The company achieved a gross margin of 25% in Q4, up from 20% in Q4 2020. Despite a net loss of $13.7 million in Q4, the company raised $84 million during its IPO. For 2022, Sonendo expects to generate between $40 million and $43 million in revenue.
Sonendo, Inc. (NYSE: SONX) has reached a significant milestone of 800,000 GentleWave patient procedures, just five months after hitting 700,000. This achievement indicates increasing adoption of the GentleWave System, a less invasive and less painful alternative to traditional root canal therapy. The milestone was celebrated by Dr. Mark Germack, who treated the 800,000th patient. Additionally, Sonendo announced investment in Area Practice Consultants to aid onboarding and practice growth for endodontists, reflecting the company's commitment to improving treatment efficacy and customer support.
Sonendo, Inc. (NYSE: SONX), a dental technology firm, will report its financial results for Q4 and the full year 2021 after market close on March 23, 2022. A conference call will follow at 1:30 PM PT / 4:30 PM ET to discuss these results. Investors can access the call by dialing (844) 200-6205 for domestic or (929) 526-1599 for international listeners, using access code: 450135. Live audio webcasts will also be available on the company's investor website.
Sonendo, Inc. (NYSE: SONX) announced preliminary revenue results for Q4 and full-year 2021. For Q4, revenue is estimated between
Sonendo, a leading dental technology firm, reported a 29% increase in total revenue for Q3 2021, totaling $7.9 million.
The GentleWave console revenue rose 44% to $1.8 million, while procedure instrument revenue climbed 30% to $3.7 million. Software revenue grew 17% to $1.7 million. The company completed its IPO on November 2, raising approximately $84 million.
For 2021, Sonendo projects total revenue between $32 million and $32.5 million.
FAQ
What is the current stock price of Sonendo (SONX)?
What is the market cap of Sonendo (SONX)?
